DOI: 10.1055/s-00000030

Der Klinikarzt

References

Miller DS, Bondarenko I, Westermann AM. et al.
Phase III randomized controlled study comparing zoptarelin with doxorubicin as second line therapy for locally advanced, recurrent, or metastatic endometrial cancer (NCT01767155).

J Clin Oncol 2018;
36 (suppl; abstr 5503) 2018

Download Bibliographical Data

Search in:
Access: